These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18220706)

  • 1. The immune system and murine atherosclerosis.
    Getz GS; Vanderlaan PA; Reardon CA
    Curr Drug Targets; 2007 Dec; 8(12):1297-306. PubMed ID: 18220706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine atherosclerosis. Part III.
    Getz GS
    Curr Drug Targets; 2008 Mar; 9(3):173. PubMed ID: 18336234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune mechanisms in atherosclerosis and potential for an atherosclerosis vaccine.
    Chyu KY; Nilsson J; Shah PK
    Discov Med; 2011 May; 11(60):403-12. PubMed ID: 21616039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined B, T and NK Cell Deficiency Accelerates Atherosclerosis in BALB/c Mice.
    Cheng F; Twardowski L; Reifenberg K; Winter K; Canisius A; Pross E; Fan J; Schmitt E; Shultz LD; Lackner KJ; Torzewski M
    PLoS One; 2016; 11(8):e0157311. PubMed ID: 27564380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Immunobiology; 2016 Sep; 221(9):1014-33. PubMed ID: 27262513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis.
    Antunes RF; Kaski JC; Dumitriu IE
    J Biomed Biotechnol; 2012; 2012():464532. PubMed ID: 22235167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine for atherosclerosis.
    Shah PK; Chyu KY; Dimayuga PC; Nilsson J
    J Am Coll Cardiol; 2014 Dec; 64(25):2779-91. PubMed ID: 25541132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies.
    Whitman SC; Ramsamy TA
    Can J Physiol Pharmacol; 2006 Jan; 84(1):67-75. PubMed ID: 16845892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells in atherosclerosis.
    Cartland SP; Jessup W
    Curr Pharm Des; 2013; 19(33):5883-90. PubMed ID: 23438964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis.
    Rahman MS; Woollard K
    Adv Exp Med Biol; 2017; 1003():121-144. PubMed ID: 28667557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of atherosclerosis.
    Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1104-15. PubMed ID: 22383700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesis.
    Lemaire-Ewing S; Lagrost L; Néel D
    Atherosclerosis; 2012 Apr; 221(2):303-10. PubMed ID: 22071358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity in Atherosclerosis: Focusing on T and B Cells.
    Poznyak AV; Bezsonov EE; Popkova TV; Starodubova AV; Orekhov AN
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive Response of T and B Cells in Atherosclerosis.
    Ketelhuth DF; Hansson GK
    Circ Res; 2016 Feb; 118(4):668-78. PubMed ID: 26892965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune system cells in atherosclerosis.
    Chávez-Sánchez L; Espinosa-Luna JE; Chávez-Rueda K; Legorreta-Haquet MV; Montoya-Díaz E; Blanco-Favela F
    Arch Med Res; 2014 Jan; 45(1):1-14. PubMed ID: 24326322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice.
    Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Willcox L; Ramsamy TA; Whitman SC
    Cardiovasc Res; 2008 Apr; 78(1):167-74. PubMed ID: 18192239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of T and B cells in atherosclerosis: potential clinical implications.
    Dumitriu IE; Kaski JC
    Curr Pharm Des; 2011 Dec; 17(37):4159-71. PubMed ID: 22204376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Two Faces of Interleukin-17A in Atherosclerosis.
    Akhavanpoor M; Akhavanpoor H; Gleissner CA; Wangler S; Doesch AO; Katus HA; Erbel C
    Curr Drug Targets; 2017; 18(7):863-873. PubMed ID: 28034277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells in the innate immunity network of atherosclerosis.
    Bonaccorsi I; De Pasquale C; Campana S; Barberi C; Cavaliere R; Benedetto F; Ferlazzo G
    Immunol Lett; 2015 Nov; 168(1):51-7. PubMed ID: 26384623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Roles of Siglecs in the Regulation of Allo-Immune Reaction.
    Cai S; Zhao J; Ueno T; Chandraker A
    Curr Protein Pept Sci; 2019; 20(8):823-828. PubMed ID: 31060487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.